Pulmonary rehabilitation (PR) is a guideline-recommended multifaceted intervention that improves the physical and psychological well-being of people with chronic respiratory diseases (CRDs), though most of the evidence derives from trials in high-resource settings. In low- and middle-income countries, PR services are under-provided. We aimed to review the effectiveness, components and mode of delivery of PR in low-resource settings. Following Cochrane methodology, we systematically searched (1990 to October 2018; pre-publication update March 2020) MEDLINE, EMBASE, CABI, AMED, PUBMED, and CENTRAL for controlled clinical trials of adults with CRD (including but not restricted to chronic obstructive pulmonary disease) comparing PR with usual care in low-resource settings. After duplicate selection, we extracted data on exercise tolerance, health-related quality of life (HRQoL), breathlessness, included components, and mode of delivery. We used Cochrane risk of bias (RoB) to assess study quality and synthesised data narratively. From 8912 hits, we included 13 studies: 11 were at high RoB; 2 at moderate RoB. PR improved functional exercise capacity in 10 studies, HRQoL in 12, and breathlessness in 9 studies. One of the two studies at moderate RoB showed no benefit. All programmes included exercise training; most provided education, chest physiotherapy, and breathing exercises. Low cost services, adapted to the setting, used limited equipment and typically combined outpatient/centre delivery with a home/community-based service. Multicomponent PR programmes can be delivered in low-resource settings, employing a range of modes of delivery. There is a need for a high-quality trial to confirm the positive findings of these high/moderate RoB studies.
The epidemiological transition from communicable to non-communicable disease (NCD) imposes a ‘double burden’ on low- and middle-income countries (LMICs)1, which continue to combat infectious diseases but are typically not yet ready to manage NCDs including chronic respiratory diseases (CRDs)2. CRDs are common3,4 and disabling5,6,7 imposing a substantial burden in LMICs. Poor awareness and insufficient resources8,9,10 in terms of infrastructure for diagnosis, availability of essential drugs, skilled health professionals, and overall healthcare priorities5 limit management options11.
Pulmonary rehabilitation (PR) is an effective component of CRD care12. PR is a comprehensive, multidisciplinary, individually tailored intervention designed to overcome the deconditioning induced by CRDs13. The components of PR include, but are not limited to, exercise programmes, chest physiotherapy, education, and supporting self-management and lifestyle change, after optimising the recommended pharmacotherapy13,14,15. PR cost-effectively reduces symptoms, morbidity, hospital admission (and readmission), duration of hospital stay, and emergency medical help and improves functional exercise capacity and health-related quality of life (HRQoL)16,17,18,19,20.
However, most of the evidence is generated from high-income countries (HICs) and is disease specific21,22,23,24 (most commonly chronic obstructive pulmonary disease (COPD)), whereas respiratory disease is often much less differentiated in LMICs. In addition, PR services as developed in HICs may not be deliverable in the same format in LMICs25,26 with substantial differences in resources, awareness, culture, healthcare configuration, and profile of diseases27,28, which may affect overall management strategy. The potential gains to individuals and healthcare economies, however, are large given the burden of disease in LMICs29,30.
Despite well-established effectiveness19,23, PR services are often unavailable even in HICs31,32,33 and uptake (by clinicians and patients) is poor particularly in LMICs and especially in rural communities34. A strategy is needed to elaborate PR programmes that are deliverable and effective in LMICs. We therefore aimed to systematically search the literature to: (1) assess the impact of PR on HRQoL and exercise capacity, when delivered in low-resource settings for people with CRD, (2) identify the components used in effective interventions, and (3) describe the models of care deliverable in low-resource settings.
Our systematic review identified 8912 records. We also found an additional 82 records from forward citation. Following the removal of duplicates, 7437 titles and abstracts were screened (Fig. 1). Fifty-six articles were reviewed in full text, with 43 articles excluded. Thirteen articles met the review criteria and were included35,36,37,38,39,40,41,42,43,44,45,46,47. No additional papers were identified in the pre-publication update. Total recruitment for the study was 661 individuals with CRD. Attrition was reported in 9 studies; 96 (20%) of the 479 subjects dropped out.
Study participants were COPD patients35,37,38,39,40,41,42,43,44,45,46,47 of varying degree of severity in all the trials except one which recruited people with pulmonary impairment after TB (PIAT)36. Total number of enrolled participants was 661 of which COPD and PIAT were 83% and 17%, respectively.
Five studies were conducted at hospital outpatient departments37,38,39,43,45 with or without continuation of exercise at home, seven were home-based35,36,40,42,44,46,47 training with or without telephonic/face-to-face monitoring or supervision, and one trial was conducted in a community centre41. Wherever the PR was delivered, all baseline and follow-up data were collected in a hospital/centre setting.
Risk of bias (RoB) assessment
Overall RoB is shown in the first column of Table 1 and detailed in Supplementary Results 1. Almost all studies were at overall high RoB, with only two studies36,39, which concealed randomisation and took steps to avoid other biases, at moderate RoB. Due to the nature of the intervention, blinding of the patients or the personnel delivering the PR was not possible, but only one study explicitly stated that outcome assessment was blind to allocation36. Attrition was a problem or was not clear in all but three studies39,41,46. None of the studies had a published protocol, so selective reporting could not be assessed.
Effectiveness of intervention (Objective 1)
Although 6-min walking test (6-MWT), St George’s Respiratory Questionnaire (SGRQ), and modified Medical Research Council (mMRC) were widely used to assess functional exercise capacity, HRQoL, and breathlessness respectively, only six of the trials presented between-group comparisons36,39,40,42,44,46. The other seven provided within-group differences35,37,38,41,43,45,47. In addition, heterogeneity in terms of mode of intervention, duration, setting, comparator, and baseline measurements confirmed our decision that meta-analysis was not appropriate.
We therefore undertook a narrative synthesis and illustrated functional exercise capacity, HRQoL, and breathless in a harvest plot (Fig. 2). Our interpretation of the study findings and the structured process determining the decisions that underpinned the harvest plot are described in column 5 of Table 1.
Changes in functional exercise capacity were measured in 11 studies35,36,37,38,39,40,41,42,43,46,47. Significant positive changes were found in 10 studies35,37,38,39,40,41,42,43,46,47; the exception being one of the two studies at moderate RoB53. HRQoL was measured in 12 studies35,37,38,39,40,41,42,43,44,45,46,47; all showing positive changes. Breathlessness was measured in 11 studies35,36,37,38,39,41,42,43,45,46,47 of which 9 studies35,37,38,39,41,42,43,45,47 showed significant positive changes and 2 studies (1 at moderate RoB)36,46 showed no changes after intervention. None of the studies reported negative effects after the intervention.
Components of the intervention (Objective 2)
All interventions included exercise and non-exercise components (as per inclusion criteria), though the approach, content, method of delivery, and duration varied. The components are described in Table 1 and their presence are indicated in a matrix in Table 2.
Endurance training was included in all 13 studies. Other common exercises were upper limb exercise35,36,37,39,45,46 and strength training in seven studies37,38,39,40,42,43,46 and stretching exercises in four studies39,42,43,45. Although not described in detail, the other common component was breathing exercises included in eight studies35,36,38,42,43,44,45,47. Along with the exercise, patient education was provided in ten studies35,36,38,39,40,41,42,43,44,46, and skills (such as inhaler technique and airway clearance) were included in seven studies35,36,39,40,42,43,47. Other components in a minority of studies were social support38, optimisation of pharmacotherapy35,37, nutrition40,42,43,44, coping strategies35,38,40,43,47, psychological intervention35,40,43,46, self-management42, and physical activity interventions43,44,46. Smoking cessation support was reported in only two studies35,44.
Models of care (Objective 3)
We identified three models of PR service in our included studies according to the settings in which they were delivered (see Table 3). Five were based in hospital or rehabilitation centres37,38,39,43,45, and one was based in a community health centre41. Only one was delivered completely at home35 while most home-based programmes36,40,42,44,46,47 provided initial training in the hospital or centre and maintained telephone40,44,46 or face-to-face supervision42,47. The programmes typically lasted 8 weeks (range 4–12), with supervised sessions lasting between 30 and 120 min provided 2 or 3 times per week. Home-based programmes promoted more frequent exercise sessions often supported by telephone or face-to-face contacts. Physiotherapists provided the sessions in six studies36,38,39,40,41,43, with nurses involved in four studies35,40,42,44. Adherence to the PR course was poorly reported with no details provided about reasons for non-completion.
Inexpensive instruments were often used in the studies, which ensured the wide availability and acceptability to the consumers. Lower limb endurance exercise was conducted by walking as opposed to expensive stationary bicycle with upper limb resistance/strength training conducted using home-made weights, such as water bottles. Breathing exercises were done with similar devices that are used in higher resource setting (e.g. incentive spirometers, tri-flow).
In summary, our systematic review identified and selected 13 heterogeneous studies from 7 different countries with a total study population of 661 patients. Overall, PR was reported as being effective in terms of improving functional exercise capacity, HRQoL, and breathlessness, though RoB was high in 11 studies. Of the two at moderate RoB, one showed no benefit in any of the outcomes reported36. The exercise programmes typically included endurance, interval, upper limb, and resistance/strength training. The commonest additional components were education to improve knowledge and skill acquisition (e.g. inhaler technique) and strategies for coping with breathlessness. Smoking cessation was provided in only two studies. Most PR services were provided in hospital settings or home based, with some describing adaptations to locally acceptable and deliverable approaches.
The strength of this systematic review is its broad literature search constructed with the help of a senior librarian and informed by Cochrane’s standard search terms for COPD and LMICs. Nevertheless, we may have missed important studies of PR conducted in low-resource settings. Although we did not specifically search for papers in other languages, we were open to including non-English language papers but none were identified in our searches, perhaps because locally conducted studies or articles in local languages are often not published in indexed journals48. We may have missed important information from these studies but lacked resources to extend the search to non-indexed publications and grey literature.
We followed rigorous Cochrane methodology duplicating the selection, data extraction, and quality assessment procedures, but confidence in our findings is limited by the high RoB in most of the studies included. We only included controlled trials because we wanted to assess effectiveness. We acknowledge, however, that in LMICs there are many challenges and barriers such as lack of infrastructure, heterogeneity of resources, and poor health literacy, which discourage clinical trials49,50. Reliable tools for measuring outcomes (e.g. validated questionnaires in local language, well-trained assessors, effective training facilities, etc.) may not be available in low-resource settings reducing accuracy of assessing effectiveness51,52. We did not search for health economic assessments.
All our included studies reported positive outcomes, but the high RoB limits interpretation of this finding. In contrast, the evidence from studies conducted in HICs are mostly at low-to-moderate RoB, so that the Cochrane review was able to conclude confidently that PR was an effective intervention for people with COPD23. It is likely that insufficient resources, training, and facilities in LMICs is responsible for the lack of high-quality trials. This is a gap that NIHR-funded initiatives, such as RESPIRE53, and RECHARGE54 aim to address.
Compared to high-resource settings, under-diagnosis due to lack of awareness of CRD compounded by limited access to diagnostic tools such as spirometry results in a minority of potentially eligible participants being approached to be enrolled in studies. Poor universal health coverage55 and ‘catastrophic’ costs of healthcare56 further limit participation in trials.
The lack of diagnostics means that patients recruited as COPD may in fact have a range of undifferentiated CRDs (e.g. pulmonary impairment after tuberculosis or combined obstructive and restrictive disorder57). While this lack of detailed characterisation may impact on findings, offering PR to people with CRD (regardless of specific diagnosis) may be a more appropriate strategy especially in resource-limited settings.
There was considerable variation in the clinical status of participants, which might affect outcomes. There was considerable range in severity of functional limitation (see Table 1). In addition, some of the patients were stable at enrolment37,39,40,43,45,47 while some had been hospitalised for a recent exacerbation38,42,44.
Exercise training is the cornerstone of PR58 and was an inclusion criterion for the studies in our review. Endurance training was included in all the studies in addition to a range of other modalities as per recognised guidelines. Behavioural changes and continuing physical activities are crucial for maintaining effectiveness of PR59, but these were not reported in any of the studies.
Education on CRD and its treatment was widely provided along with strategies on managing breathlessness, but other components such as self-management support and addressing social care needs were rarely reported, despite evidence of effectiveness in CRDs60. In HICs, smoking is the predominant risk factor and cessation support is seen as essential. Surprisingly, only two of the studies in our review reported a smoking cessation component and none reported avoidance of pollution and indoor biomass exposure, which are also important risk factors in LMICs61,62. The brief descriptions in the papers make it difficult to assess how these and other important educational topics (such as inhaler technique) were addressed.
Models of PR delivery depends on who, where, to whom, and how the service is delivered63. Different models of PR services were described in the included studies reflecting diversity in the healthcare context and access to PR services; individuals’ health literacy; and background beliefs, attitudes, and preferences, as well as practical factors such as availability of transport and capability of payment64. A home-based, inexpensively equipped PR service with minimal attendance at a potentially distant centre may be more suitable model in rural areas with limited resources and poor transport infrastructure65,66. In home-based models, the cost to the patient is minimised, and people have flexibility in how they invest their time67,68,69. Digital technology is a rising paradigm in LMICs, which may be considered in developing a remote model of PR service70.
Our findings have implications for clinical practice and research. Breathlessness is the principal symptom that drives the patients with CRDs to seek medical help71. In LMICs, diagnosis of chronic respiratory symptoms depends on clinical history and physical examination, with limited, or sometimes no, access to spirometry or other investigations72. Poor healthcare coverage may mean that tasks regarded as prerequisites to referral in HICs, such as identifying co-morbidities, optimising pharmacotherapy, and exclusion of contraindications, may need to be a component of PR in LMICs73. The studies included in this review identified some practical solutions to these challenges, but high-quality evidence of the clinical and cost effectiveness of these pragmatic approaches is urgently needed.
In conclusion, recommendations in PR guidelines typically reflect services delivered in high-income settings. Our literature review, although identifying studies with high-to-moderate RoB, highlighted the feasibility of conducting PR in LMICs with positive effects on outcomes such as exercise tolerance, HRQoL, and symptoms improvement. Our findings point to the need for PR services that are effective across a broad range of (potentially poorly differentiated) CRDs, overcoming barriers of cost, distance, and access to healthcare such that they are deliverable and sustainable in low-resource settings with minimal equipment. Only then will the known benefits of PR be available to address the increasing burden of CRDs in LMICs.
Published review protocol
The review is registered with PROSPERO [ID: CRD42019125326]. The detailed systematic review protocol is published74 with salient points described here. We followed the procedures described in the Cochrane Handbook for Systematic Reviews of Interventions75.
Deviation from published protocol
We planned to use Grading of Recommendations Assessment Development and Evaluation (GRADE76) approach to rate the quality of evidence for primary outcomes and the important secondary outcomes; however, there was substantial missing information in the papers, so we were unable to apply the GRADE approach (see Supplementary Results 2 for our limited GRADE exercise).
Table 4 gives details of the search strategy developed to detect randomised controlled trials (RCTs) and controlled clinical trials of ‘Pulmonary Rehabilitation’ AND ‘COPD or other CRD’ AND ‘LMIC or low-resource settings’ from 1990 (when global COPD guidelines first recommended PR77) to November 2018 with no language restrictions. We searched MEDLINE (Supplementary Methods 1) EMBASE, Global Health (CABI), AMED, PubMed, and the Cochrane Database of Controlled Trials (CENTRAL). We did not undertake hand searching as we found no journal that regularly published PR papers in LMICs. Additionally, we conducted forward citations of the included articles. We used EndNote for overall data management.
The searches were completed on 28 October 2018, with a pre-publication update on 8 March 2020 using the ‘efficient and effective’ approach78 of forward citation using Google Scholar, of all included papers, and the Cochrane review23.
Details of inclusion and exclusion criteria and definitions used are in Table 4. In summary, we undertook a duplicate selection process using rules for operationalising the inclusion/exclusion criteria (see protocol for details74). Two trained reviewers (G.M.M.H. and M.N.U.) independently screened titles and abstracts, then full-text papers (G.M.M.H., M.N.U., and K.D.). Disagreements were resolved by discussion, involving H.P. and R.R. or the wider team as necessary. We reported the process in a PRISMA flow diagram (Fig. 1)79.
Our primary outcomes were between-group difference in functional exercise capacity (e.g. 6-MWT80,81,82) and HRQoL (e.g. SGRQ83,84). We also included breathlessness (e.g. mMRC Dyspnoea score85). These are defined, and secondary outcomes are described in Table 4.
Data extraction and RoB
Two reviewers (G.M.M.H. and M.N.U. and checked by H.P.) extracted data on a piloted data extraction form (Supplementary Methods 2) based on the Cochrane Effective Practice and Organisation of Care guidance86; G.M.M.H. and M.N.U. (checked by H.P.) independently assessed the methodological quality of all the included studies according to the Cochrane RoB tool75.
The analysis addressed our three objectives:
Effectiveness of PR in low-resource settings: On the basis of our initial scoping, we anticipated that our included studies would have substantial clinical, methodological, and statistical heterogeneity, and meta-analysis would not be appropriate. We, therefore, conducted a narrative synthesis illustrating the key outcomes on a harvest plot87,88. In order to ensure transparency of interpretation, the decisions that underpinned the harvest plot are described in Table 1: column 5.
Components used in effective studies: We identified the components that are described in internationally recognised guidelines13,15,89 using categories from the American Thoracic Society/European Respiratory Society task force report13, British Thoracic Society guidelines for PR15, and Lung Foundation of Australia90. We then constructed a matrix with the components used in the (effective and ineffective) studies.
Models of care used in the PR interventions: We described the models of care used, including PR providers and (if specified) their training, venue and equipment available, number and frequency of training sessions, use of telehealth, and strategies for sustainability.
Data sharing is not applicable as no data sets were produced during this study. The data that support the findings of this systematic review are all available in the published papers.
Ahmed, R., Robinson, R. & Mortimer, K. The epidemiology of noncommunicable respiratory disease in sub-Saharan Africa, the Middle East, and North Africa. Malawi Med. J. 29, 203–211 (2017).
Shayo, F. K. & Bintabara, D. Are Tanzanian health facilities ready to provide management of chronic respiratory diseases? An analysis of national survey for policy implications. PLoS ONE 14, e0210350 (2019).
World Health Organisation. Global alliance against chronic respiratory diseases. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. https://www.who.int/respiratory/en/ (2007).
Ferkol, T. & Schraufnagel, D. The global burden of respiratory disease. Ann. Am. Thorac. Soc. 11, 404–406 (2014).
India State-Level Disease Burden Initiative CRD Collaborators. The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990-2016. Lancet Glob. Health 6, e1363–e1374 (2018).
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1859–1922 (2018).
Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386, 743–800 (2015).
Adeloye, D. et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J. Glob. Health 5, 020415 (2015).
Alam, D. S., Chowdhury, M. A., Siddiquee, A. T., Ahmed, S. & Clemens, J. D. Prevalence and determinants of chronic obstructive pulmonary disease (COPD) in Bangladesh. COPD 12, 658–667 (2015).
Islam, M. S., Hossain, M. M., Pasha, M. M., Azad, A. K. & Murshed, K. M. Prevalence and risk factors of chronic obstructive pulmonary disease (COPD) in Dhaka city population. Mymensingh Med. J. 22, 547–551 (2013).
Ait-Khaled, N., Enarson, D. & Bousquet, J. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull. World Health Organ. 79, 971–979 (2001).
Troosters, T., Blondeel, A., Rodrigues, F. M., Janssens, W. & Demeyer, H. Strategies to increase physical activity in chronic respiratory diseases. Clin. Chest Med. 40, 397–404 (2019).
Rochester, C. L. et al. An Official American Thoracic Society/European Respiratory Society Policy Statement: enhancing implementation, use, and delivery of pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 192, 1373–1386 (2015).
Global Initiative for Chronic Obstractive Lung Disease. Pocket guide to COPD diagnosis, management and prevention. https://goldcopd.org/ (2019).
Bolton, C. E. et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax 68(Suppl 2), ii1–ii30 (2013).
Golmohammadi, K., Jacobs, P. & Sin, D. D. Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease. Lung 182, 187–196 (2004).
Griffiths, T. L., Phillips, C. J., Davies, S., Burr, M. L. & Campbell, I. A. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 56, 779–784 (2001).
Puhan, M., Scharplatz, M., Troosters, T., Walters, E. H. & Steurer, J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. Cd005305 (2009).
Puhan, M. A., Gimeno-Santos, E., Cates, C. J. & Troosters, T. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 12, Cd005305 (2016).
Seymour, J. M. et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax 65, 423–428 (2010).
Araujo, Z. T. S. et al. Pulmonary rehabilitation for people with chronic obstructive pulmonary disease: A protocol for an overview of Cochrane reviews. Medicine 98, e17129 (2019).
Jenkins, A. R. et al. Efficacy of supervised maintenance exercise following pulmonary rehabilitation on health care use: a systematic review and meta-analysis. Int. J. Chron. Obstruct. Pulmon. Dis. 13, 257–273 (2018).
McCarthy, B. et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. Cd003793 (2015).
Roberts, N. J., Kidd, L., Kirkwood, K., Cross, J. & Partridge, M. R. A systematic review of the content and delivery of education in pulmonary rehabilitation programmes. Respir. Med. 145, 161–181 (2018).
Black, R. E. Prevention in developing countries. J. Gen. Intern. Med. 5, S132–S135 (1990).
Gothi, D. & Joshi, J. M. Pulmonary rehabilitation in resource poor settings. Indian J. Chest Dis. Allied Sci. 53, 163–172 (2011).
Han, W. Health care system reforms in developing countries. J. Public Health Res. 1, 199–207 (2012).
Kumar, R. Universal health coverage - time to dismantle vertical public health programs in India. J. Fam. Med. Prim. Care 8, 1295–1296 (2019).
Heine, M. et al. Exercise-based rehabilitation for major non-communicable diseases in low-resource settings: a scoping review. BMJ Glob. Health 4, e001833 (2019).
Forum of International Respiratory Societies. The global impact of respiratory disease. https://www.who.int/gard/publications/The_Global_Impact_of_Respiratory_Disease.pdf (2017).
Brooks, D., Lacasse, Y. & Goldstein, R. S. Pulmonary rehabilitation programs in Canada: national survey. Can. Respir. J. 6, 55–63 (1999).
Wadell, K. et al. Hospital-based pulmonary rehabilitation in patients with COPD in Sweden-a national survey. Respir. Med. 107, 1195–1200 (2013).
Yohannes, A. M. & Connolly, M. J. Pulmonary rehabilitation programmes in the UK: a national representative survey. Clin. Rehabil. 18, 444–449 (2004).
Desalu, O. O. et al. Guideline-based COPD management in a resource-limited setting - physicians’ understanding, adherence and barriers: a cross-sectional survey of internal and family medicine hospital-based physicians in Nigeria. Prim. Care Respir. J. 22, 79–85 (2013).
Akinci, A. C. & Olgun, N. The effectiveness of nurse-led, home-based pulmonary rehabilitation in patients with COPD in Turkey. Rehabil. Nurs. 36, 159–165 (2011).
de Grass, D., Manie, S. & Amosum, S. Effectiveness of a home-based pulmonary rehabilitation programme in pulmonary function and health related quality of life for patients with pulmonary tuberculosis: a pilot study. Afr. Health Sci. 14, 866–872 (2014).
de Souto Araujo, Z. T. et al. Effectiveness of low-intensity aquatic exercise on COPD: a randomized clinical trial. Respir. Med. 106, 1535–1543 (2012).
Deepak, T. H., Mohapatra, P. R., Janmeja, A. K., Sood, P. & Gupta, M. Outcome of pulmonary rehabilitation in patients after acute exacerbation of chronic obstructive pulmonary disease. Indian J. Chest Dis. Allied Sci. 56, 7–12 (2014).
Duruturk, N., Arıkan, H., Ulubay, G. & Tekindal, M. A. A comparison of calisthenic and cycle exercise training in chronic obstructive pulmonary disease patients: a randomized controlled trial. Expert Rev. Respir. Med. 10, 99–108 (2016).
Elci, A., Börekçi, Ş., Ovayolu, N. & Elbek, O. The efficacy and applicability of a pulmonary rehabilitation programme for patients with COPD in a secondary-care community hospital. Respirology 13, 703–707 (2008).
Farias, C. C. et al. Costs and benefits of pulmonary rehabilitation in chronic obstructive pulmonary disease: a randomized controlled trial. Braz. J. Phys. Ther. 18, 165–173 (2014).
Ghanem, M., ELaal, E. A., Mehany, M. & Tolba, K. Home-based pulmonary rehabilitation program: effect on exercise tolerance and quality of life in chronic obstructive pulmonary disease patients. Ann. Thorac. Med. 5, 18 (2010).
Karapolat, H. et al. Do the benefits gained using a short-term pulmonary rehabilitation program remain in COPD patients after participation? Lung 185, 221–225 (2007).
Mohammadi, F., Jowkar, Z., Reza Khankeh, H. & Fallah Tafti, S. Effect of home-based nursing pulmonary rehabilitation on patients with chronic obstructive pulmonary disease: a randomised clinical trial. Br. J. Community Nurs. 18, 398–403 (2013).
Paz-Díaz, H., De Oca, M. M., López, J. M. & Celli, B. R. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am. J. Phys. Med. Rehabil. 86, 30–36 (2007).
Pradella, C. O. et al. Home-based pulmonary rehabilitation for subjects with COPD: a randomized study. Respir. Care 60, 526–532 (2015).
Singh, V., Khandelwal, D. C., Khandelwal, R. & Abusaria, S. Pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Indian J. Chest Dis. Allied Sci. 45, 13–17 (2003).
Bennett, S. et al. Influencing policy change: the experience of health think tanks in low-and middle-income countries. Health Policy Plan. 27, 194–203 (2012).
Grover, S. et al. Clinical trials in low and middle-income countries—successes and challenges. Gynecol. Oncol. Rep. 19, 5–9 (2017).
Osei, A. Challenges of clinical trials in low-and middle-income countries. Int. Psychiatry 9, 30–31 (2012).
Maters, G. A., Sanderman, R., Kim, A. Y. & Coyne, J. C. Problems in cross-cultural use of the hospital anxiety and depression scale: “no butterflies in the desert”. PLoS ONE 8, e70975 (2013).
Singh, S. J., Halpin, D. M., Salvi, S., Kirenga, B. J. & Mortimer, K. Exercise and pulmonary rehabilitation for people with chronic lung disease in LMICs: challenges and opportunities. Lancet Respir. Med. 7, 1002–1004 (2019).
Sheikh, A. et al. RESPIRE: The National Institute for Health Research’s (NIHR) Global Respiratory Health Unit. J. Glob. Health 8, 020101 (2018).
Free, R. C. et al. The RECHARGE database: towards a global standard for pulmonary rehabilitation (PR). Eur. Respir. J. 54, PA693 (2019).
Wiysonge, C. S. et al. Financial arrangements for health systems in low-income countries: an overview of systematic reviews. Cochrane Database Syst. Rev. CD011084 (2017).
Khan, J. A. M., Ahmed, S. & Evans, T. G. Catastrophic healthcare expenditure and poverty related to out-of-pocket payments for healthcare in Bangladesh-an estimation of financial risk protection of universal health coverage. Health Policy Plan. 32, 1102–10. (2017).
Mortimer, K., Cuevas, L., Squire, B., Thomson, R. & Tolhurst, R. Improving access to effective care for people with chronic respiratory symptoms in low and middle income countries. BMC Proc. 9, S3 (2015).
Troosters, T., Gosselink, R., Janssens, W. & Decramer, M. Exercise training and pulmonary rehabilitation: new insights and remaining challenges. Eur. Respir. Rev. 19, 24–29 (2010).
Pfeifer, K. & Geidl, W. Physical activity recommendations for adults with a chronic disease: methods, database and rationale. Gesundheitswesen 79, S29–S35 (2017).
Quaak, M., Schayck, Van, Knaapen, C., Van, A. & Schooten, F. Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur. Respir. J. 33, 468–480 (2009).
Rajendra, K., Shukla, S. D., Gautam, S. S., Hansbro, P. M. & O’Toole, R. F. The role of environmental exposure to non-cigarette smoke in lung disease. Clin. Transl. Med. 7, 1–12 (2018).
Varkey, A. B. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr. Opin. Pulm. Med. 10, 98–103 (2004).
Furlan, A. D. et al. Rehabilitation service models for people with physical and/or mental disability living in low-and middle-income countries: a systematic review. J. Rehabil. Med. 50, 487–498 (2018).
Heine, M. et al. Patient-centred rehabilitation for non-communicable disease in a low-resource setting: study protocol for a feasibility and proof-of-concept randomised clinical trial. BMJ Open 9, e025732 (2019).
Horton, E. J. et al. Comparison of a structured home-based rehabilitation programme with conventional supervised pulmonary rehabilitation: a randomised non-inferiority trial. Thorax 73, 29–36 (2018).
José, A. et al. Does home-based pulmonary rehabilitation improve functional capacity, peripheral muscle strength and quality of life in patients with bronchiectasis compared to standard care? Braz. J. Phys. Ther. 21, 473–480 (2017).
Liu, X. L. et al. Effectiveness of home-based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials. Rehabil. Nurs. 39, 36–59 (2014).
Macrea, M., ZuWallack, R. & Nici, L. There’s no place like home: integrating pulmonary rehabilitation into the home setting. Monaldi Arch. Chest Dis. 87, 859 (2017).
Zwerink, M. et al. Cost-effectiveness of a community-based exercise programme in COPD self-management. COPD 13, 214–223 (2016).
Pinnock, H. & McKinstry, B. Digital technology in respiratory diseases: promises,(no) panacea and time for a new paradigm. Chron. Respir. Dis. 13, 189–191 (2016).
Hutchinson, A., Barclay-Klingle, N., Galvin, K. & Johnson, M. J. Living with breathlessness: a systematic literature review and qualitative synthesis. Eur. Respir. J. 51, 1701477 (2018).
Siddharthan, T. et al. Effectiveness-implementation of COPD case finding and self-management action plans in low-and middle-income countries: global excellence in COPD outcomes (GECo) study protocol. Trials 19, 571 (2018).
Patel, M. R. et al. Improving the affordability of prescription medications for people with chronic respiratory disease. An official American Thoracic Society policy statement. Am. J. Respir. Crit. Care Med. 198, 1367–1374 (2018).
Habib, G. M. M. et al. Systematic review (protocol) of clinical effectiveness and models of care of low-resource pulmonary rehabilitation. NPJ Prim. Care Respir. Med. 29, 10 (2019).
Higgins, J. P. T. & Green, S. (eds) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] (The Cochrane Collaboration, 2011).
GRADE Working Group. Grading of recommendations assessment, development and evaluation (GRADE). https://www.gradeworkinggroup.org/ (2012).
Casaburi, R. A brief history of pulmonary rehabilitation. Respir. Care 53, 1185–1189 (2008).
Greenhalgh, T. & Peacock, R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. BMJ 331, 1064–1065 (2005).
Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Ann. Int. Med. 151, W-65 (2009).
Bohannon, R. W. & Crouch, R. Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review. J. Eval. Clin. Pract. 23, 377–381 (2017).
Lima, C. A. et al. Six-minute walk test as a determinant of the functional capacity of children and adolescents with cystic fibrosis: a systematic review. Respir. Med. 137, 83–88 (2018).
Brooks, G. C. et al. Accuracy and usability of a self-administered 6-minute walk test smartphone application. Circ. Heart Fail. 8, 905–913 (2015).
American Thoracic Society (ATS). St. George’s Respiratory Questionnaire (SGRQ). https://www.thoracic.org/members/assemblies/assemblies/srn/questionaires/sgrq.php (2016).
Jones, P., Quirk, F. & Baveystock, C. The St George’s Respiratory Questionnaire. Respir. Med. 85, 25–31 (1991).
Munari, A. B. et al. Modified Medical Research Council dyspnea scale in GOLD classification better reflects physical activities of daily living. Respir. Care 63, 77–85 (2018).
Effective Practice and Organisation of Care (EPOC) Group. Data collection form. EPOC resources for review authors. https://epoc.cochrane.org/about-us (2013).
Ogilvie, D. et al. The harvest plot: a method for synthesising evidence about the differential effects of interventions. BMC Med. Res. Methodol. 8, 8 (2008).
Crowther, M., Avenell, A., MacLennan, G. & Mowatt, G. A further use for the harvest plot: a novel method for the presentation of data synthesis. Res. Synth. Methods 2, 79–83 (2011).
Spruit, M. A. et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 188, e13–e64 (2013).
Alison, J. A. et al. Australian and New Zealand Pulmonary Rehabilitation Guidelines. Respirology 22, 800–819 (2017).
We acknowledge the contribution of Marshall Dozier, academic librarian of The University of Edinburgh, in helping develop the search strategy. We also acknowledge the logistic support provided by Sebastien George, Postgraduate Research Administrator, Usher Institute of The University of Edinburgh. G.M.M.H. and S.A. are supported by PhD studentships from the NIHR Global Health Research Unit on Respiratory Health (RESPIRE) and M.N.U. is a RESPIRE Fellow. RESPIRE is funded by the National Institute of Health Research using the Official Development Assistance (ODA) funding. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. The RESPIRE collaboration comprises the UK Grant holders, Partners, and research teams as listed on the RESPIRE website (www.ed.ac.uk/usher/respire), including Moira Whyte, Steve Cunningham, Li Ping Wong, Aisha Holloway, Osman Yusuf, Sanjay Juvekar, Andrew Morris, Colin Simpson, Sian Williams, Ehsan Rahman, Saturnino Luz, Tabish Hazir, Aziz Sheikh, and Harry Campbell.
Neither the funder nor the sponsor (University of Edinburgh) contributed to protocol development. G.M.M.H. owns a pulmonary rehabilitation clinic in Bangladesh. All other authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Habib, G.M., Rabinovich, R., Divgi, K. et al. Systematic review of clinical effectiveness, components, and delivery of pulmonary rehabilitation in low-resource settings. npj Prim. Care Respir. Med. 30, 52 (2020). https://doi.org/10.1038/s41533-020-00210-y
This article is cited by
A feasibility trial of pulmonary rehabilitation for patients with COPD in a low resource setting: Jaffna, Sri Lanka
BMC Pulmonary Medicine (2022)
Exploring the barriers to pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a qualitative study
BMC Health Services Research (2021)